RECRUITING

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of study is to evaluate whether home visit programs are an effective method for HTN and T2DM management as compared to standard of care clinic visits.

Official Title

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

Quick Facts

Study Start:2022-07-27
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05168605

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 60 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult patients ages 18-60
  2. * Spanish or English speaking
  3. * Diagnosis of HTN or BP \>140/90 in last 3 months (based on medical record)
  4. * Hemoglobin A1C\>8 in last 6 months (based on medical record)
  5. * Not pregnant
  1. * Current oral steroid use
  2. * History of solid organ transplant
  3. * Language other than English or Spanish

Contacts and Locations

Study Contact

Silvia Obregon, MSW
CONTACT
214-645-9532
silvia.obregon@utsouthwestern.edu

Principal Investigator

Nora Gimpel, M.D.
PRINCIPAL_INVESTIGATOR
UT Southwestern Medical Center

Study Locations (Sites)

UT Southwestern Medical Center
Dallas, Texas, 75390
United States

Collaborators and Investigators

Sponsor: University of Texas Southwestern Medical Center

  • Nora Gimpel, M.D., PRINCIPAL_INVESTIGATOR, UT Southwestern Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-07-27
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2022-07-27
Study Completion Date2024-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Hypertension
  • Type 2 Diabetes